LIQUI-TAB

Serial Number 90527927
734

Registration Progress

Application Filed
Feb 12, 2021
Under Examination
Sep 27, 2022
Approved for Publication
Feb 8, 2022
Published for Opposition
Feb 8, 2022
Registered

Attorney Assistance

Statement of Use Due - Extension 5 Granted
Due: Sep 27, 2025 56 days
Statement of Use required (all extensions used)

Trademark Image

LIQUI-TAB

Basic Information

Serial Number
90527927
Filing Date
February 12, 2021
Published for Opposition
February 8, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
734
Status Date
Jul 11, 2025
Application
Pending
Classes
005

Rights Holder

Infirst Healthcare Inc.

03
Address
8 Church Lane
2nd Floor
Westport, CT 06880

Ownership History

Infirst Healthcare Inc.

Original Applicant
03
Westport, CT

Infirst Healthcare Inc.

Owner at Publication
03
Westport, CT

Legal Representation

Attorney
Dean G. Stathakis

USPTO Deadlines

Next Deadline
56 days remaining
Statement of Use Due - Extension 5 Granted
Due Date
September 27, 2025

Application History

38 events
Date Code Type Description Documents
Jul 11, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 11, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 11, 2025 EX5G S SOU EXTENSION 5 GRANTED Loading...
Mar 21, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 20, 2025 EXT5 S SOU EXTENSION 5 FILED Loading...
Sep 27, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Sep 27, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Sep 27, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 27, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 23, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 22, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Mar 22, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Mar 22, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 29, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 27, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Sep 27, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Sep 27, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 2, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 28, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 25, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Mar 25, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Mar 25, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 27, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Aug 18, 2022 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Mar 9, 2022 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Feb 8, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 8, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 19, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 4, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 24, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 24, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 24, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 26, 2021 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 26, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
May 26, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...
May 18, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
May 17, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 16, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations in chewable tablet dosage form, for the treatment of sleep, cough, cold, and flu, and pain relief; Pharmaceutical preparations, namely, a drug delivery system comprising chewable tablets and polymer-based oral tablets for the release of a wide variety of therapeutic agents; dietary supplements

Additional Information

Pseudo Mark
LIQUID-TAB

Classification

International Classes
005